vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Cricut, Inc. (CRCT). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $203.6M, roughly 1.8× Cricut, Inc.). Cricut, Inc. runs the higher net margin — 3.8% vs -0.8%, a 4.6% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs -2.7%). Over the past eight quarters, Cricut, Inc.'s revenue compounded faster (10.3% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Cricut, Inc. is an American brand of cutting plotters, or computer-controlled cutting machines, designed for home crafters. The machines are used for cutting paper, felt, vinyl, fabric and other materials such as leather, matboard, and wood.
ASIX vs CRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $359.9M | $203.6M |
| Net Profit | $-2.8M | $7.8M |
| Gross Margin | 7.6% | 47.4% |
| Operating Margin | -0.7% | 6.8% |
| Net Margin | -0.8% | 3.8% |
| Revenue YoY | 9.4% | -2.7% |
| Net Profit YoY | -892.9% | -34.7% |
| EPS (diluted) | $-0.11 | $0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $203.6M | ||
| Q3 25 | $374.5M | $170.4M | ||
| Q2 25 | $410.0M | $172.1M | ||
| Q1 25 | $377.8M | $162.6M | ||
| Q4 24 | $329.1M | $209.3M | ||
| Q3 24 | $398.2M | $167.9M | ||
| Q2 24 | $453.5M | $167.9M | ||
| Q1 24 | $336.8M | $167.4M |
| Q4 25 | $-2.8M | $7.8M | ||
| Q3 25 | $-2.6M | $20.5M | ||
| Q2 25 | $31.4M | $24.5M | ||
| Q1 25 | $23.3M | $23.9M | ||
| Q4 24 | $352.0K | $11.9M | ||
| Q3 24 | $22.3M | $11.5M | ||
| Q2 24 | $38.9M | $19.8M | ||
| Q1 24 | $-17.4M | $19.6M |
| Q4 25 | 7.6% | 47.4% | ||
| Q3 25 | 6.8% | 55.2% | ||
| Q2 25 | 14.3% | 59.0% | ||
| Q1 25 | 14.2% | 60.5% | ||
| Q4 24 | 3.4% | 44.9% | ||
| Q3 24 | 14.4% | 46.1% | ||
| Q2 24 | 17.9% | 53.5% | ||
| Q1 24 | 0.9% | 54.7% |
| Q4 25 | -0.7% | 6.8% | ||
| Q3 25 | -0.9% | 13.3% | ||
| Q2 25 | 7.7% | 17.5% | ||
| Q1 25 | 7.7% | 18.0% | ||
| Q4 24 | -3.9% | 6.6% | ||
| Q3 24 | 7.5% | 6.3% | ||
| Q2 24 | 11.5% | 15.7% | ||
| Q1 24 | -7.0% | 15.1% |
| Q4 25 | -0.8% | 3.8% | ||
| Q3 25 | -0.7% | 12.0% | ||
| Q2 25 | 7.7% | 14.2% | ||
| Q1 25 | 6.2% | 14.7% | ||
| Q4 24 | 0.1% | 5.7% | ||
| Q3 24 | 5.6% | 6.8% | ||
| Q2 24 | 8.6% | 11.8% | ||
| Q1 24 | -5.2% | 11.7% |
| Q4 25 | $-0.11 | $0.03 | ||
| Q3 25 | $-0.10 | $0.10 | ||
| Q2 25 | $1.15 | $0.11 | ||
| Q1 25 | $0.86 | $0.11 | ||
| Q4 24 | $0.02 | $0.06 | ||
| Q3 24 | $0.82 | $0.05 | ||
| Q2 24 | $1.43 | $0.09 | ||
| Q1 24 | $-0.65 | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $275.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $343.6M |
| Total Assets | $1.7B | $580.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $275.6M | ||
| Q3 25 | $23.7M | $207.1M | ||
| Q2 25 | $18.4M | $376.9M | ||
| Q1 25 | $8.3M | $356.7M | ||
| Q4 24 | $19.6M | $336.9M | ||
| Q3 24 | $17.3M | $246.9M | ||
| Q2 24 | $12.1M | $299.5M | ||
| Q1 24 | $20.6M | $281.7M |
| Q4 25 | $815.2M | $343.6M | ||
| Q3 25 | $818.2M | $358.4M | ||
| Q2 25 | $823.7M | $308.9M | ||
| Q1 25 | $794.4M | $490.2M | ||
| Q4 24 | $774.6M | $466.8M | ||
| Q3 24 | $766.4M | $475.8M | ||
| Q2 24 | $746.6M | $448.5M | ||
| Q1 24 | $713.2M | $552.6M |
| Q4 25 | $1.7B | $580.8M | ||
| Q3 25 | $1.7B | $564.3M | ||
| Q2 25 | $1.6B | $721.5M | ||
| Q1 25 | $1.6B | $681.7M | ||
| Q4 24 | $1.6B | $693.0M | ||
| Q3 24 | $1.5B | $663.8M | ||
| Q2 24 | $1.5B | $742.1M | ||
| Q1 24 | $1.5B | $723.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $82.4M |
| Free Cash FlowOCF − Capex | $36.1M | — |
| FCF MarginFCF / Revenue | 10.0% | — |
| Capex IntensityCapex / Revenue | 7.7% | — |
| Cash ConversionOCF / Net Profit | — | 10.58× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $82.4M | ||
| Q3 25 | $26.6M | $20.5M | ||
| Q2 25 | $21.1M | $36.2M | ||
| Q1 25 | $11.4M | $61.2M | ||
| Q4 24 | $64.2M | $103.1M | ||
| Q3 24 | $57.3M | $70.2M | ||
| Q2 24 | $50.2M | $35.0M | ||
| Q1 24 | $-36.2M | $56.7M |
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $26.8M | — | ||
| Q2 24 | $16.7M | — | ||
| Q1 24 | $-71.6M | — |
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | -6.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | -21.3% | — |
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | 10.5% | — |
| Q4 25 | — | 10.58× | ||
| Q3 25 | — | 1.00× | ||
| Q2 25 | 0.67× | 1.48× | ||
| Q1 25 | 0.49× | 2.56× | ||
| Q4 24 | 182.29× | 8.64× | ||
| Q3 24 | 2.57× | 6.11× | ||
| Q2 24 | 1.29× | 1.77× | ||
| Q1 24 | — | 2.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
CRCT
| Platform | $83.9M | 41% |
| Connected Machines | $65.2M | 32% |
| Accessories And Materials | $54.4M | 27% |